Evidence map›Paper›PMID 29891780›Full record

ReviewJournal of clinical medicine2018

The Role of Procalcitonin in the Diagnosis of Meningitis: A Literature Review.

Dimitrios Velissaris, Martina Pintea, Nikolaos Pantzaris, Eirini Spatha, Vassilios Karamouzos, Charalampos Pierrakos, Menelaos Karanikolas

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Procalcitonin measurement in West Nile virus neuroinvasive disease: A first case series.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Dimitrios VelissarisDepartment of Medicine, University of Patras, 26504 Patras, Greece. dimitrisvelissaris@yahoo.com.
Martina PinteaUniversity of Medicine and Pharmacy, 400337 Cluj-Napoca, România. martina.pintea@yahoo.com.
Nikolaos PantzarisSchool of Medicine University of Patras, 26500 Patras, Greece. npantzaris@gmail.com.
Eirini SpathaSchool of Medicine University of Patras, 26500 Patras, Greece. eirini.spatha@outlook.com.
Vassilios KaramouzosIntensive Care Unit, University Hospital of Patras, Rion 26500, Greece. karamouzos@hotmail.com.
Charalampos PierrakosIntensive Care Department, Brugmann University Hospital, 1020 Brussels, Belgium. charalampos.pierrakos@chu-brugmann.be.
Menelaos KaranikolasDepartment of Anesthesiology, Washington University School of Medicine, St. Louis, MO 63144, USA. menelaos.karanikolas@wustl.edu.ORCID 0000-0001-8541-7988
University of Patras · GRCentre Hospitalier Universitaire Brugmann · BEGeneral University Hospital of Patras · GRWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo review the current published literature on the use of procalcitonin as a diagnostic and prognostic marker in adult patients with meningitis.

methodsWe conducted a PubMed search to identify all relevant publications regarding the diagnostic and prognostic value of serum procalcitonin in patients with a known or suspected central nervous system infection. We also reviewed the bibliographies of all identified manuscripts in an attempt to identify additional relevant references.

resultsA significant body of evidence suggests that serum procalcitonin has a promising role and can be a useful biomarker in the assessment of patients with meningitis.

conclusionsOur literature review suggests that data on the role of Cerebrospinal Fluid (CSF) procalcitonin are limited, whereas serum procalcitonin (S⁻PCT) is probably a useful tool in the evaluation of patients with a known or suspected central nervous system infection and can help distinguish between bacterial and viral meningitis.

Indexed as

antibiotic therapybacterial meningitisbiomarkerdifferential diagnosisprocalcitoninviral meningitis

Identifiers

PMID29891780
PMCPMC6025317
OpenAlexW2807267447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.